CorMedix (CRMD) Gross Profit Growth (5y) (2018 - 2025)
CorMedix (CRMD) Gross Profit Growth (5y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
832.98% |
| Sep 30, 2025 |
489.21% |
| Jun 30, 2025 |
573.13% |
| Mar 31, 2025 |
329.87% |
| Dec 31, 2024 |
326.36% |
| Sep 30, 2024 |
253.81% |
| Jun 30, 2024 |
83.77% |
| Mar 31, 2024 |
-66.87% |
| Dec 31, 2022 |
-28.41% |
| Sep 30, 2022 |
24.23% |
| Jun 30, 2022 |
-29.26% |
| Mar 31, 2022 |
16.14% |
| Dec 31, 2021 |
197.50% |
| Sep 30, 2021 |
89.48% |
| Jun 30, 2021 |
48.41% |
| Mar 31, 2021 |
38.29% |
| Dec 31, 2020 |
-60.85% |
| Sep 30, 2020 |
566.04% |
| Jun 30, 2020 |
-173.94% |
| Mar 31, 2020 |
348.96% |
